MIT Enterprise Forum of Cambridge Features Case Presentation by Codon Devices, Synthetic Biology Pioneer

Business Wire, Feb 14, 2007

Industry Experts to Discuss Marketing and Business Issues for Biotech Companies Targeting Major Pharmaceutical Firms

CAMBRIDGE, Mass. -- The MIT Enterprise Forum of Cambridge

What: The MIT Enterprise Forum of Cambridge will host a case
presentation by John Danner, president and CEO of Codon Devices, a
privately held biotechnology company focused on enabling commercial
applications of synthetic biology. Codon Devices' proprietary
BioFAB(TM) production platform is expected to enable large-scale
biological research, engineered cells that produce novel
pharmaceuticals, improved vaccines, agricultural products and
biorefineries for the production of industrial chemicals and energy.

Panelists: The following panelists will join Danner in discussing
effective approaches to selling novel drug development technologies
to "big pharma," strategic partnerships and funding strategies.

Martha Dunn, Ph.D. - Global Manager of Biotechnology Licensing,
  Syngenta Biotechnology, Inc.
Don Munoz - Managing Director, Head of Medical Technology Investment
  Banking, Leerink Swann
Jules Musing - Vice President of Global Licensing and Business
  Development, Johnson & Johnson

When: February 21, 2007
Networking: 5:30 p.m.
Program: 6:15 p.m.

Where: Stata Center (Bldg. 32), Kirsch Auditorium, 1st floor, 32
  Vassar Street, Cambridge

Co-Sponsors: Foley Hoag LLP and the Massachusetts Biotechnology
  Council

Registration and information:

http://www.mitforumcambridge.org/feb07.html

Forum members: $20; Non-members: $30; Students from all universities, free with college ID.